Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Urinary Tract Infections 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Pain 1 Neutropenia 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1 Infections 1 Hypokalemia 1 Hypertension 1 Hyperaldosteronism 1 Herpes Simplex 1 Hemophilia A 1 Hemangioma, Capillary 1 Heart Failure 1 Heart Arrest 1

Interventions

Surveys and Questionnaires 70 Blood Specimen Collection 60 palbociclib 37 Trastuzumab 31 Letrozole 26 Immunohistochemistry 26 Drug Therapy 24 Anastrozole 24 Radiotherapy 21 Gene Expression Profiling 20 Amplified Fragment Length Polymorphism Analysis 20 Mastectomy, Segmental 19 Biopsy 19 Tamoxifen 18 exemestane 17 Interviews as Topic 17 ribociclib 16 Mastectomy 16 Fulvestrant 16 Paclitaxel 15 Magnetic Resonance Spectroscopy 15 Psychiatric Rehabilitation 14 High-Energy Shock Waves 14 Polymerase Chain Reaction 13 Observation 13 Microarray Analysis 13 Capecitabine 13 trastuzumab deruxtecan 12 Neoadjuvant Therapy 12 Specimen Handling 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Breast Neoplasms × Rocuronium × Clear all

NCT05681611 2023-10-19

Effect of Rocuronium on BIS Values

University of Padova

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡